Skip to main content
. 2009 Mar 2;136(1):237–244. doi: 10.1378/chest.08-2697

Table 2.

Characteristics of PGD Case Patients and Control Subjects

Characteristics No. Case Patients (n = 20) Control Subjects (n = 61) p Value
Recipient variables
    Age, yr 81 49 ± 14 54 ± 12 0.18
    Female sex 81 8 (40) 25 (42) 0.94
    Race/ethnicity 81 0.02
        Non-Hispanic white 15 (75) 57 (93)
        Black 5 (25) 3 (5)
        Hispanic 1 (2)
    Diagnosis 81 0.03
        COPD 5 (25) 32 (52)
        Diffuse parenchymal lung disease 12 (60) 16 (26)
        Cystic fibrosis 1 (5) 9 (15)
        Other 2 (10) 4 (7)
Donor variables
    Age, yr 81 30 ± 13 32 ± 14 0.69
    Female sex 81 8 (40) 25 (41) 0.94
    Race/ethnicity 81 0.30
        Non-Hispanic white 18 (90) 43 (71)
        Black 8 (13)
        Hispanic 2 (10) 8 (13)
        Other 2 (3)
Surgical variables
    Bilateral transplant 81 13 (65) 37 (61) 0.73
    Use of CPB 81 14 (70) 11 (18) < 0.001
    mPAP at induction, mm Hg 61 40 ± 14 25 ± 9 < 0.001
    Ischemic time, min 77 286 (257–375) 300 (235–352) 0.50
    Packed RBCs during first 24 h, mL 81 875 (0–1,500) 250 (0–750) 0.05
    Platelets during first 24 h, mL 81 0 (0–622) 0 (0–0) < 0.001
    Fresh frozen plasma during first 24 h, mL 81 363 (0–1,053) 0 (0–0) 0.002

Values are given as the mean ± SD, No. (%), or median (IQR), unless otherwise indicated.